Andrew Sheely
Technik-/Wissenschafts-/F&E-Leiter bei VERVE THERAPEUTICS, INC.
Profil
Andrew Sheely is currently the Vice President of Information Technology at Verve Therapeutics, Inc. Previously, he held positions as the Head of Information Technology at Dyax Corp., Kaleido Biosciences, Inc., and CRISPR Therapeutics, Inc. He completed his undergraduate degree at the University of Rhode Island and his graduate degree at Regis University.
Aktive Positionen von Andrew Sheely
| Unternehmen | Position | Beginn |
|---|---|---|
| VERVE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Andrew Sheely
| Unternehmen | Position | Ende |
|---|---|---|
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Technik-/Wissenschafts-/F&E-Leiter | - |
| DYAX CORP. | Technik-/Wissenschafts-/F&E-Leiter | - |
| KALEIDO BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Andrew Sheely
| University of Rhode Island | Undergraduate Degree |
| Regis University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
